Understanding Treatment Resistance: VHIR’s Role in CancerScan
The Clinical Challenge One of the greatest challenges in PDAC (Pancreatic Ductal Adenocarcinoma) treatment is that therapy selection currently relies on performance status assessme
CancerScan Digital Twin System receives EMA Breakthrough Device designation
The CancerScan Digital Twin System, a medical device being developed within the CancerScan Project, has received EMA Breakthrough Device designation through the EMA Breakthrough Me